For many people, the path to bariatric surgery runs through the health conditions that excess weight has caused or worsened. These are called comorbidities. Understanding which conditions are taken seriously in the eligibility assessment, and how they factor into the decision, is important whether you are pursuing surgery through the NHS or privately.
How comorbidities affect eligibility
Under NICE guidelines, a person with a BMI between 35 and 39.9 who would not otherwise meet the standard threshold can qualify for bariatric surgery if they have at least one significant obesity-related health condition. The condition must be one that has not responded adequately to non-surgical interventions, or where surgery offers a clinically meaningful advantage over continued medical management.
Private providers and overseas centres vary in how strictly they apply these criteria, but the underlying principle is the same: comorbidities shift the risk-benefit calculation in favour of surgical intervention by adding clinical urgency to the decision.
Type 2 diabetes
Type 2 diabetes is one of the most compelling comorbidities for bariatric surgery, and the evidence behind surgery as a treatment for it is strong. Remission rates following sleeve gastrectomy are high, often above 50 percent, with improvements in blood sugar occurring within days of surgery before significant weight loss has occurred. This points to hormonal and metabolic mechanisms beyond simple calorie reduction.
James had pre-diabetic markers before surgery, not confirmed type 2 diabetes. But the direction of travel was clear. Within three months of surgery, those markers had normalised. For someone already diagnosed with type 2 diabetes, particularly if blood sugar is poorly controlled on medication, surgery is supported by strong clinical evidence as an effective treatment.
Non-alcoholic fatty liver disease
NAFLD is one of the conditions that most directly factored into James’s case for surgery. He had been living with NAFLD for over ten years and was approaching stage 3 liver failure at the time of surgery. This is a condition that can progress to cirrhosis and liver failure if not addressed, and weight loss is the most effective intervention for reversing it. James’s liver function returned to normal within three weeks of surgery. The speed and completeness of that reversal was one of the most striking outcomes of the entire process.
High blood pressure
Obesity-related hypertension is a common comorbidity that qualifies for consideration. Both James and Kirsten had elevated blood pressure before surgery. Both saw their blood pressure normalise within three months post-operatively, along with other metabolic markers. Sustained hypertension carries significant cardiovascular risk, and reducing it without lifelong medication is a meaningful clinical outcome.
Joint disease and mobility problems
Obesity places mechanical stress on the joints, particularly the knees, hips, and lower back. Severe osteoarthritis or mobility limitation that is directly attributed to weight is a clinically relevant comorbidity. It is particularly significant where the mobility limitation itself prevents meaningful exercise-based weight loss, creating a situation where surgery may be the only realistic route to reducing joint load.
Polycystic ovary syndrome
PCOS, which affects hormonal balance, menstrual regularity, and fertility, has a well-established link to excess weight and insulin resistance. Significant weight loss, including through surgery, can meaningfully improve PCOS symptoms, restore ovulatory cycles, and improve fertility outcomes. For women with PCOS who have been unable to achieve significant weight loss through other means, this is a recognised indication.
Cardiovascular disease and metabolic syndrome
Elevated cardiovascular risk from the combination of abdominal obesity, dyslipidaemia, hypertension, and insulin resistance, sometimes called metabolic syndrome, is a recognised indication for surgical consideration, particularly where the cluster of risk factors is not responding adequately to lifestyle and medication.
What matters most
The key principle is that the comorbidity must be genuine, documented, and clinically significant. Having a slightly elevated reading on one occasion is not the same as a diagnosed, managed, ongoing condition. For an NHS referral, your GP will need to document the relevant conditions and your history of trying to address them through non-surgical means. For private assessment, a thorough clinical history covering all relevant conditions will be part of the consultation.
Sources
NICE: Obesity: identification, assessment and management (NG238). NHS: Weight loss surgery. BOMSS: Commissioning guide for bariatric surgery. Lean MEJ et al: Primary care-led weight management for remission of type 2 diabetes. The Lancet 2018.
About this content
This blog is written by James and Kirsten, a couple from the UK who had gastric sleeve surgery together in March 2024.
We started this blog because we couldn't find any sources of content that details before surgery, the surgery and then life post surgery - so we decided to write one ourselves.
Everything on this site is based on our own experience and the research we have done along the way. It is not medical advice. Gastric sleeve surgery is a serious procedure and every patient's journey is different. Please always consult your own bariatric team or GP before making any decisions about your health or treatment.
Some posts on this site may contain featured or sponsored content, or affiliate links. Where this is the case, it will always be clearly stated at the top of the article. Our opinions are always our own.
Publish Date: 31 May 2026 | Last Reviewed: 7 June 2026 | Next Planned Review: 7 December 2027